{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Infuse&page=2", "query": { "intervention": "Infuse", "page": 2 }, "page_size": 10 }, "pagination": { "page": 2, "page_size": 10, "total_count": 10, "total_pages": 1, "next_page_url": null, "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Infuse&page=1&page_size=10" }, "source": "remote", "last_synced_at": "2026-09-05T22:35:38.186Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT04040452", "title": "Continuous vs Intermittent Ketorolac for Pain Control in Peds CV Surgery", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Congenital Heart Disease in Children" ], "interventions": [ { "name": "Continuous ketorolac", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Phoenix Children's Hospital", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "3 Months", "maximum_age": "59 Months", "sex": "ALL", "summary": "3 Months to 59 Months" }, "enrollment_count": 166, "start_date": "2021-03-01", "completion_date": "2027-12-01", "has_results": false, "last_update_posted_date": "2026-08-12", "last_synced_at": "2026-09-05T22:35:38.186Z", "location_count": 1, "location_summary": "Phoenix, Arizona", "locations": [ { "city": "Phoenix", "state": "Arizona" } ], "official_url": "https://clinicaltrials.gov/study/NCT04040452" }, { "nct_id": "NCT01931046", "title": "Use of Recombinant Adenovirus Therapy to Treat Localized Prostate Cancer", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1", "PHASE2" ], "conditions": [ "Localized Prostate Cancer" ], "interventions": [ { "name": "Ad5-SGE-REIC/Dkk3", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Momotaro-Gene Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "50 Years", "maximum_age": "80 Years", "sex": "MALE", "summary": "50 Years to 80 Years · Male only" }, "enrollment_count": 28, "start_date": "2013-10", "completion_date": "2020-03", "has_results": false, "last_update_posted_date": "2020-09-04", "last_synced_at": "2026-09-05T22:35:38.186Z", "location_count": 3, "location_summary": "San Diego, California • Boston, Massachusetts • Houston, Texas", "locations": [ { "city": "San Diego", "state": "California" }, { "city": "Boston", "state": "Massachusetts" }, { "city": "Houston", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT01931046" }, { "nct_id": "NCT00002718", "title": "T-cell Depleted Bone Marrow and G-CSF Stimulated Peripheral Stem Cell Transplantation From Related Donors in Treating Patients With Leukemia, Lymphoblastic Lymphoma, Myelodysplastic Syndrome, or Aplastic Anemia", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Leukemia", "Lymphoma", "Myelodysplastic Syndromes", "Myelodysplastic/Myeloproliferative Neoplasms" ], "interventions": [ { "name": "anti-thymocyte globulin", "type": "BIOLOGICAL" }, { "name": "filgrastim", "type": "BIOLOGICAL" }, { "name": "cyclophosphamide", "type": "DRUG" }, { "name": "cytarabine", "type": "DRUG" }, { "name": "methylprednisolone", "type": "DRUG" }, { "name": "thiotepa", "type": "DRUG" }, { "name": "in vitro-treated bone marrow transplantation", "type": "PROCEDURE" }, { "name": "in vitro-treated peripheral blood stem cell transplantation", "type": "PROCEDURE" }, { "name": "radiation therapy", "type": "RADIATION" } ], "intervention_types": [ "BIOLOGICAL", "DRUG", "PROCEDURE", "RADIATION" ], "sponsor": "Memorial Sloan Kettering Cancer Center", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": null, "maximum_age": "49 Years", "sex": "ALL", "summary": "Up to 49 Years" }, "enrollment_count": 31, "start_date": "1995-11", "completion_date": "2008-10", "has_results": false, "last_update_posted_date": "2015-12-23", "last_synced_at": "2026-09-05T22:35:38.186Z", "location_count": 1, "location_summary": "New York, New York", "locations": [ { "city": "New York", "state": "New York" } ], "official_url": "https://clinicaltrials.gov/study/NCT00002718" }, { "nct_id": "NCT04410042", "title": "Tranexamic Acid Use to Reduce Blood Transfusion in Pediatric Cancer Patients Undergoing Limb Salvage Procedure", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Cancer of the Bone", "Limb Salvage" ], "interventions": [ { "name": "Tranexamic Acid", "type": "DRUG" }, { "name": "0.9% sodium chloride", "type": "OTHER" } ], "intervention_types": [ "DRUG", "OTHER" ], "sponsor": "St. Jude Children's Research Hospital", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": null, "maximum_age": "24 Years", "sex": "ALL", "summary": "Up to 24 Years" }, "enrollment_count": 15, "start_date": "2021-01-29", "completion_date": "2024-01-16", "has_results": true, "last_update_posted_date": "2024-12-20", "last_synced_at": "2026-09-05T22:35:38.186Z", "location_count": 1, "location_summary": "Memphis, Tennessee", "locations": [ { "city": "Memphis", "state": "Tennessee" } ], "official_url": "https://clinicaltrials.gov/study/NCT04410042" }, { "nct_id": "NCT03192462", "title": "TAA Specific Cytotoxic T Lymphocytes in Patients With Pancreatic Cancer", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1", "PHASE2" ], "conditions": [ "Pancreatic Cancer" ], "interventions": [ { "name": "multiTAA specific T cells", "type": "BIOLOGICAL" } ], "intervention_types": [ "BIOLOGICAL" ], "sponsor": "Baylor College of Medicine", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 37, "start_date": "2018-01-18", "completion_date": "2025-07-31", "has_results": true, "last_update_posted_date": "2025-10-29", "last_synced_at": "2026-09-05T22:35:38.186Z", "location_count": 3, "location_summary": "Houston, Texas", "locations": [ { "city": "Houston", "state": "Texas" }, { "city": "Houston", "state": "Texas" }, { "city": "Houston", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT03192462" }, { "nct_id": "NCT07076160", "title": "Pilot Dispensing Study of Two Marketed Daily Disposable Multifocal Contact Lenses", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Visual Acuity", "Presbyopia" ], "interventions": [ { "name": "INFUSE® One Day Multifocal", "type": "DEVICE" }, { "name": "ACUVUE® OASYS MAX 1-Day Multifocal Contact Lens", "type": "DEVICE" } ], "intervention_types": [ "DEVICE" ], "sponsor": "Johnson & Johnson Vision Care, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "40 Years", "maximum_age": "70 Years", "sex": "ALL", "summary": "40 Years to 70 Years" }, "enrollment_count": 74, "start_date": "2025-07-24", "completion_date": "2025-09-20", "has_results": false, "last_update_posted_date": "2026-08-28", "last_synced_at": "2026-09-05T22:35:38.186Z", "location_count": 7, "location_summary": "Jacksonville, Florida • Longwood, Florida • Maitland, Florida + 3 more", "locations": [ { "city": "Jacksonville", "state": "Florida" }, { "city": "Jacksonville", "state": "Florida" }, { "city": "Longwood", "state": "Florida" }, { "city": "Maitland", "state": "Florida" }, { "city": "Vestal", "state": "New York" } ], "official_url": "https://clinicaltrials.gov/study/NCT07076160" }, { "nct_id": "NCT03642626", "title": "MT2017-45: CAR-T Cell Therapy for Heme Malignancies", "overall_status": "ACTIVE_NOT_RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Acute Lymphoblastic Leukemia", "Large B-cell Lymphoma" ], "interventions": [ { "name": "KYMRIAH", "type": "DRUG" }, { "name": "YESCARTA", "type": "DRUG" }, { "name": "Fludarabine 30mg/m2 4 doses", "type": "DRUG" }, { "name": "Cyclophosphamide 500 mg/m2; 2 doses", "type": "DRUG" }, { "name": "Fludarabine 30mg/m2 3 doses", "type": "DRUG" }, { "name": "Cyclophosphamide 500 mg/m2; 3 doses", "type": "DRUG" }, { "name": "Fludarabine 25mg/m2 3 days", "type": "DRUG" }, { "name": "Cyclophosphamide 250 mg/m2; 3 days", "type": "DRUG" }, { "name": "Tecartus", "type": "DRUG" }, { "name": "Abecma, Intravenous Suspension", "type": "DRUG" }, { "name": "Cyclophosphamide 900 mg/m2; 1 day", "type": "DRUG" }, { "name": "Breyanzi Injectable Product", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Masonic Cancer Center, University of Minnesota", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": null, "maximum_age": null, "sex": "ALL", "summary": "Not listed" }, "enrollment_count": 150, "start_date": "2018-12-18", "completion_date": "2028-06-01", "has_results": true, "last_update_posted_date": "2026-01-23", "last_synced_at": "2026-09-05T22:35:38.186Z", "location_count": 1, "location_summary": "Minneapolis, Minnesota", "locations": [ { "city": "Minneapolis", "state": "Minnesota" } ], "official_url": "https://clinicaltrials.gov/study/NCT03642626" }, { "nct_id": "NCT00274846", "title": "Donor Peripheral Stem Cell Transplant in Treating Patients With Relapsed Acute Myeloid Leukemia", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Leukemia" ], "interventions": [ { "name": "aldesleukin", "type": "BIOLOGICAL" }, { "name": "therapeutic allogeneic lymphocytes", "type": "BIOLOGICAL" }, { "name": "cyclophosphamide", "type": "DRUG" }, { "name": "fludarabine phosphate", "type": "DRUG" }, { "name": "in vitro treated peripheral blood stem cell transplantation", "type": "PROCEDURE" } ], "intervention_types": [ "BIOLOGICAL", "DRUG", "PROCEDURE" ], "sponsor": "Masonic Cancer Center, University of Minnesota", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "2 Years", "maximum_age": null, "sex": "ALL", "summary": "2 Years and older" }, "enrollment_count": 21, "start_date": "2005-03", "completion_date": "2008-06", "has_results": true, "last_update_posted_date": "2017-12-28", "last_synced_at": "2026-09-05T22:35:38.186Z", "location_count": 1, "location_summary": "Minneapolis, Minnesota", "locations": [ { "city": "Minneapolis", "state": "Minnesota" } ], "official_url": "https://clinicaltrials.gov/study/NCT00274846" }, { "nct_id": "NCT03787732", "title": "Preventing Cardiovascular Collapse With Administration of Fluid Resuscitation During Induction and Intubation", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Acute Respiratory Failure", "Intubation Complication", "Hypotension on Induction" ], "interventions": [ { "name": "Fluid Bolus", "type": "DRUG" }, { "name": "No Fluid Bolus", "type": "OTHER" } ], "intervention_types": [ "DRUG", "OTHER" ], "sponsor": "Vanderbilt University Medical Center", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 1067, "start_date": "2019-02-01", "completion_date": "2021-06-21", "has_results": false, "last_update_posted_date": "2021-08-12", "last_synced_at": "2026-09-05T22:35:38.186Z", "location_count": 11, "location_summary": "Birmingham, Alabama • New Orleans, Louisiana • Burlington, Massachusetts + 7 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "New Orleans", "state": "Louisiana" }, { "city": "New Orleans", "state": "Louisiana" }, { "city": "Burlington", "state": "Massachusetts" }, { "city": "Minneapolis", "state": "Minnesota" } ], "official_url": "https://clinicaltrials.gov/study/NCT03787732" }, { "nct_id": "NCT01430299", "title": "Efficacy and Safety of Accell Evo3 Demineralized Bone Matrix (DBM) in Instrumented Posterolateral Lumbar Spine Fusion", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Stenosis", "Spondylosis", "Degenerative Changes" ], "interventions": [ { "name": "Demineralized Bone Matrix", "type": "DEVICE" }, { "name": "rh-BMP2", "type": "DEVICE" } ], "intervention_types": [ "DEVICE" ], "sponsor": "SeaSpine, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 43, "start_date": "2011-06", "completion_date": "2016-10", "has_results": true, "last_update_posted_date": "2018-06-07", "last_synced_at": "2026-09-05T22:35:38.186Z", "location_count": 1, "location_summary": "Sacramento, California", "locations": [ { "city": "Sacramento", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT01430299" } ] }